Clinical Trials Logo
  1. Home
  2. Tourette Syndrome in Adolescence
  3. NCT05188274

A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome

Tourette Syndrome in Adolescence Clinical Trial

Official title:
A Multicenter, Randomized, Double-blind, and Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome

Clinical Trial Summary

A 12-week clinical study to evaluate the safety and efficacy of T92 in pediatric patients with Tourette Syndrome.

Clinical Trial Description

This is a multi-center, randomized, double-blind, placebo-controlled, outpatient clinical study designed to evaluate the efficacy and safety of T92 in Tourette Syndrome pediatric patients. This trial consists of a screening/wash-out period of up to 6 weeks, an 8-week supportive care period and a 4-week follow-up period for all subjects who completed the study. For the first two weeks, the patients will continue to take T92 at half dose and the T92 administration will be stopped from week 3 of the follow-up period. Subjects will be randomly assigned to receive T92 or matching placebo based on individual body weight. The calculated amount of investigational product (T92 or placebo) will be administrated orally twice daily. Morning dose and evening dose should be administrated at about the same time every day and irrelevant to meals. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05188274
Study type Interventional
Source Tasly Pharmaceuticals, Inc.
Contact Michael H Bloch, MD, PhD
Phone 203-974-7551
Email michael.bloch@yale.edu
Status Not yet recruiting
Phase N/A
Start date May 2022
Completion date October 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05566236 - Board Game Project for Adolescents With Tourette Syndrome N/A
Completed NCT04114539 - Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT05558566 - Neurofeedback From the Supplementary Motor Area for Tourette Syndrome N/A
Recruiting NCT05628805 - Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome Early Phase 1
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT05184478 - Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study Phase 1/Phase 2
Recruiting NCT05696769 - Tourette Discrimination (TD) Stigma Scale
Completed NCT04449003 - Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
Recruiting NCT04087616 - Internet-based CBIT for Children With Chronic Tics N/A
Completed NCT03765463 - Extinction Learning in Youth With Tourette Syndrome N/A
Completed NCT05434546 - A Study to Explore the Effect of Sepranolone in Tourette Syndrome Phase 2
Not yet recruiting NCT04179435 - Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome N/A